Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Is an acute ischemic stroke patients with evidence of intracranial vascular occlusion
- Is enrolled within 8 hours of symptom onset
- Has treatment plan that includes stent retriever
- Has protocol-defined scores on several scales

Exclusion Criteria

- Has treatment plan that includes fibrinolysis or fibinolysis
- Has identified intracranial hemorrhage or subarachnoid hemorrhage
- Has active bleeding like gastrointestinal hemorrhage
- Has cerebral bleeding risk; intracranial tumor, brain aneurysm, cerebral arteriovenous malformation, or history of intracranial bleeding
- Has severe hepatic or renal impairment
- Has been a participant in other clinical trial within 30 days prior to treatment
- Is pregnant, lactating, or planning on becoming pregnant during treatment period
- Has any condition or history that might, per protocol or in the opinion of the investigator, compromise:
1. safety or well-being of the participant or their offspring
2. safety of the study staff
3. analysis of results